Abstract: Memory devices and methods of forming memory devices are described. Methods of forming electronic devices are described where carbon is used as the removable mold material for the formation of a DRAM capacitor. A dense, high-temperature (500° C. or greater) PECVD carbon material is used as the removable mold material, e.g., the core material, instead of oxide. The carbon material can be removed by isotropic etching with exposure to radicals of oxygen (O2), nitrogen (N2), hydrogen (H2), ammonia (NH3), and combinations thereof.

Abstract: The present disclosure describes methods and/or apparatus for gripping a plurality of types of circuit boards. For example, a method may include: gripping a first circuit board using a first sub-gripper of an integrated mechanical gripper, wherein the integrated mechanical gripper comprises a plurality of sub-grippers; placing the first circuit board into a transfer platform; gripping the first circuit board from the transfer platform using a second sub-gripper of the plurality of sub-grippers, flipping the first circuit board, and placing the flipped first circuit board into a splitter; splitting the first circuit board into at least one second circuit board with a different type or size from the first circuit board; and gripping the second circuit board from the splitter using a third sub-gripper of the plurality of sub-grippers.

Abstract: Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, tautomer, prodrug or stereoisomer thereof, wherein R1, R2a, R3a, R3b, R4a, R4b, G1, G2, L1, L2, m1, m2, A, B, W, X, Y, Z and E are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of G12C mutant KRAS protein for treatment of disorders, such as cancer, are also provided.

Abstract: A robotic cleaner may include one or more driven wheels, at least one environmental sensor, and a mop module. The mop module may include a tank having a tank inlet and a tank outlet, a pad coupled at a bottom side of the tank, the pad configured to contact a surface to be cleaned and to receive liquid from the tank outlet, and a latch configured to transition between a latched position, a release position, and a refill position. When in the latched position and in the release position, at least a portion of the latch may extend over the tank inlet and, when in the refill position, the latch may be displaced from the tank inlet, exposing the tank inlet.

Abstract: A method may include providing a substrate, where the substrate includes a first main surface and a second main surface, opposite the first main surface. The second main surface may include a stress compensation layer. The method may include directing ions to the stress compensation layer in an ion implant procedure. The ion implant procedure may include exposing a first region of the stress compensation layer to a first implant process, wherein a second region of the stress compensation layer is not exposed to the first implant process.

Abstract: This application discloses a sound acquisition component array, including: two first sound acquisition components, two second sound acquisition components, and two third sound acquisition components. The two second sound acquisition components are located at a first side of a line connecting the two first sound acquisition components, and the two third sound acquisition components are located at a second side of the connecting line that is opposite to the first side of the connecting line; the two second sound acquisition components are symmetrical about a perpendicular bisector of the connecting line, and the two third sound acquisition components are symmetrical about the perpendicular bisector; and a distance between the two first sound acquisition components, a distance between the two second sound acquisition components, and a distance between the two third sound acquisition components are respectively different from one another along a direction defined by the connecting line.

Abstract: An electrical connecting assembly includes a first connecting member, a second connecting member, and two pairs of differential conducting wires connected between the first connecting member and the second connecting member and provided to be adjacent to each other. Polarity arrangements of the first cable core and the second cable core of one pair of differential conducting wires at a first end thereof and at a second end thereof are opposite to each other, and polarity arrangements of the first cable core and the second cable core of the other pair of differential conducting wires at a first end thereof and at a second end thereof are identical to each other. The invention may reduce the remote crosstalk of the electrical connecting assembly, and performance of the remote crosstalk characteristics thereof in high frequency is good.

Abstract: Compounds with KRAS G12C inhibitory active are disclosed and methods of using the same to treat a cancer comprising a K-Ras G12C mutation.

Abstract: The present disclosure provides allogeneic cells that cause reduced, minimal, or no risks of graft-versus-host disease (GVHD) and reduced, minimal, or no risk of CD4, CD8 and NK cell rejections, for example, when used to treat diseases in a patient. The allogeneic cells may be genetically engineered to reduce the expression or activity of MHC class I and/or MHC class II molecules, such as knocking out the RFX5 gene. Methods of preparing and using such allogeneic cells are also provided.

Abstract: A sonar target locking system to position a sonar assembly to maintain the sonar array of the sonar assembly pointing at a position of a user set (desired) target even when the watercraft is rotating or moving in various motions. The sonar target locking system includes electro-mechanical assembly that can be steered electrically to maintain the sonar array pointing at the position of the desired target. The system may be activated using at least one of a foot pedal, handheld remote control, or a display of a fish finder head unit. The system may use GPS and IMU inputs to generate control signals to steer the electro-mechanical assembly to maintain the sonar array pointing at the position of the desired target.

Abstract: Embodiments of the present disclosure provide a method and apparatus for processing a message header, a storage medium, and an electronic apparatus.

Abstract: A method of forming a semiconductor device may include forming a plurality of fins extending from a buried oxide layer, wherein a masking layer is disposed atop each of the plurality of fins, and performing a high-temperature ion implant to the semiconductor device. The method may further include performing an etch process to remove the masking layer from atop each of the plurality of fins, wherein the etch process does not remove the buried oxide layer.

Abstract: An interface circuit includes a phase inverter. An input end of the phase inverter is connected to a signal output end of a first power domain circuit, and an output end of the phase inverter is connected to a signal input end of a second power domain circuit. A power end of the phase inverter is connected to a power supply of the first power domain circuit, and a ground end of the phase inverter is connected to a reference ground of the second power domain circuit. Alternatively, a power end of the phase inverter is connected to a power supply of the second power domain circuit, and a ground end of the phase inverter is connected to a reference ground of the first power domain circuit.

Abstract: Microorganisms and microbial production methods for the biosynthesis of ester compounds are provided. Useful examples employ microorganisms that have been genetically modified to express alcohol acyltransferases, either from other species or that have been modified to increase their activity in catalyzing the esterification of alcohols. Additional useful examples employ microorganisms that have been genetically modified to express lipases, either from other species or that have been modified to increase their activity in catalyzing the esterification of organic acids. Additional modifications are presented that significantly increase ester production.

Abstract: Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, tautomer, prodrug or stereoisomer thereof, wherein R1, R2a, R3a, R3b, R4a, R4b, G1, G2, L1, L2, m1, m2, A, B, W, X, Y, Z and E are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of G12C mutant KRAS protein for treatment of disorders, such as cancer, are also provided.

Abstract: Disclosed are chimeric antigen receptors (CARs), comprising an antigen binding domain, a transmembrane domain; a costimulatory domain; and a signaling domain comprising one of a CD3? signaling domain, a CD3? signaling domain, a CD3? signaling domain, or a DAP12 signaling domain. Disclosed is a nucleic acid encoding a CAR and recombinant vector comprising such nucleic acids. Disclosed is a host cell comprising such nucleic acids and recombinant vectors, and a pharmaceutical composition comprising such host cells. Disclosed is method of treating disease in a patient in need of thereof, or inducing an immune response in a subject or immunizing a subject against a cancer.

Abstract: Provided in the embodiments of the present disclosure are a method and device for processing a data packet, a storage medium, and an electronic device. The method includes: in a case where a Bit-Forwarding Ingress Router (BFIR) performs Bit Index Explicit Replication (BIER) packet encapsulation and outer Internet Protocol Version 6 (IPv6) packet encapsulation on a data packet, copying an Entropy field in a BIER packet header to a position of a Flow Label field of an outer IPv6 packet, and placing a label value allocated for Virtual Private Network (VPN) data in a position of the original Entropy field in the BIER packet header; and setting a data packet after the BIER packet header, and setting a Proto field in the BIER packet header to a corresponding value indicating a data packet type of the data packet.

Abstract: A displaying method and apparatus for application performance management are disclosed. The method includes obtaining data from a target application; mapping the data into a plurality of dimensions; displaying a plurality of layers corresponding to the plurality of dimensions; and displaying, based on a dimension associated with an object supported by the target application, a visualized node corresponding to the object at a corresponding layer of the plurality of layers.

Abstract: A light reflection assembly includes a reflection element, a substrate, a first cantilever beam, a second cantilever beam, a magnetic structure, and a support structure. The substrate is located on the magnetic structure, the reflection element is located in a hollow region in the middle of the substrate. Two ends of the reflection element are connected to the substrate through the first cantilever beam and the second cantilever beam, respectively. The first cantilever beam and second cantilever beam are located on different sides of the reflection element and are disposed along a first axial direction. A front side of the reflection element is configured to reflect incident light. The magnetic structure is configured to drive the reflection element to rotate. The support structure is fastened to the magnetic structure. An end of the support structure is in contact with a back side of the reflection element.

Abstract: The present disclosure provides compounds and methods for inhibiting the interaction of menin with its upstream or downstream signaling molecules including but not limited to MLL1, MLL2 and MLL-fusion oncoproteins. Compounds of the disclosure may be used in methods for the treatment of a wide variety of cancers and other diseases associated with one or more of MLL1, MLL2, MLL fusion proteins, and menin.